Hi-

With respect to June/July NIH deadlines, I am assuming that most
institutions will advise investigators to develop a full itemized budget,
round the total direct costs to the nearest $25,000, divide by the number
of grant years, and request the result per year.
[This assumes no variation in modules...but my questions pertain to either
situation].

Question:
Does anyone anticipate systems-related problems, particularly in
continuation years, stemming from the difference between in-house budget
and actual NIH award?

Is the need to hang on to surplus in early years an unrealistic (or simply
unusual) demand of grant administrators/managers?

Any plans for mitigation?

Charlie Hathaway

**************************************
Charles B. Hathaway, Ph.D., Director
Office of Grant Support
908A Belfer
Albert Einstein College of Medicine
1300 Morris Park Avenue
Bronx, NY 10461
Phone: 718 430-3642     Fax: 718 430-8822
email: xxxxxx@aecom.yu.edu
http://www.aecom.yu.edu/ogs

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================